Vivo Ventures Vi Affiilates Fund, L.p. - Net Worth and Insider Trading

Vivo Ventures Vi Affiilates Fund, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Vivo Ventures Vi Affiilates Fund, L.p. owns 3 companies in total, including Eiger BioPharmaceuticals Inc (EIGRQ) , Sagent Pharmaceuticals Inc (SGNT) , and KalVista Pharmaceuticals Inc (KALV) .

Click here to see the complete history of Vivo Ventures Vi Affiilates Fund, L.p.’s form 4 insider trades.

Insider Ownership Summary of Vivo Ventures Vi Affiilates Fund, L.p.

Ticker	Comapny	Transaction Date	Type of Owner
EIGRQ	Eiger BioPharmaceuticals Inc	2016-03-22	other: affiliate
SGNT	Sagent Pharmaceuticals Inc	2016-04-21	10 percent owner
KALV	KalVista Pharmaceuticals Inc	2015-04-08	10 percent owner

Vivo Ventures Vi Affiilates Fund, L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Vivo Ventures Vi Affiilates Fund, L.p. Ownership Network

Ownership Network List of Vivo Ventures Vi Affiilates Fund, L.p.

No Data

Ownership Network Relation of Vivo Ventures Vi Affiilates Fund, L.p.

Vivo Ventures Vi Affiilates Fund, L.p. Owned Company Details

What does Eiger BioPharmaceuticals Inc do?

Who are the key executives at Eiger BioPharmaceuticals Inc?

Vivo Ventures Vi Affiilates Fund, L.p. is the other: affiliate of Eiger BioPharmaceuticals Inc. Other key executives at Eiger BioPharmaceuticals Inc include 10 percent owner Richard A Kayne , 10 percent owner Leen Kawas , and Chief Business Officer Ingrid Choong .

Eiger BioPharmaceuticals Inc (EIGRQ) Insider Trades Summary

Over the past 18 months, Vivo Ventures Vi Affiilates Fund, L.p. made no insider transaction in Eiger BioPharmaceuticals Inc (EIGRQ). Other recent insider transactions involving Eiger BioPharmaceuticals Inc (EIGRQ) include a net purchase of 278,239 shares made by Richard A Kayne , and a net purchase of 24,332 shares made by Leen Kawas .

In summary, during the past 3 months, insiders sold 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) were sold and 10,086 shares were bought by its insiders, resulting in a net purchase of 10,086 shares.

Eiger BioPharmaceuticals Inc (EIGRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Eiger BioPharmaceuticals Inc Insider Transactions

No Available Data

What does Sagent Pharmaceuticals Inc do?

Who are the key executives at Sagent Pharmaceuticals Inc?

Vivo Ventures Vi Affiilates Fund, L.p. is the 10 percent owner of Sagent Pharmaceuticals Inc. Other key executives at Sagent Pharmaceuticals Inc include 10 percent owner Vivo Ventures V, Llc , 10 percent owner Vivo Ventures V Affiliates Fund, L.p. , and 10 percent owner Vivo Ventures Fund V, L.p. .

Sagent Pharmaceuticals Inc (SGNT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sagent Pharmaceuticals Inc (SGNT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sagent Pharmaceuticals Inc (SGNT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sagent Pharmaceuticals Inc (SGNT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sagent Pharmaceuticals Inc Insider Transactions

No Available Data

What does KalVista Pharmaceuticals Inc do?

Who are the key executives at KalVista Pharmaceuticals Inc?

Vivo Ventures Vi Affiilates Fund, L.p. is the 10 percent owner of KalVista Pharmaceuticals Inc. Other key executives at KalVista Pharmaceuticals Inc include CFO and Secretary Benjamin L Palleiko , Chief Medical Officer Paul K. Audhya , and Chief Development Officer Christopher Yea .

KalVista Pharmaceuticals Inc (KALV) Insider Trades Summary

Over the past 18 months, Vivo Ventures Vi Affiilates Fund, L.p. made no insider transaction in KalVista Pharmaceuticals Inc (KALV). Other recent insider transactions involving KalVista Pharmaceuticals Inc (KALV) include a net purchase of 1,251,017 shares made by Venrock Healthcare Capital Partners Iii, L.p. , a net sale of 144,760 shares made by Benjamin L Palleiko , and a net sale of 116,267 shares made by Edward P. Feener .

In summary, during the past 3 months, insiders sold 40,693 shares of KalVista Pharmaceuticals Inc (KALV) in total and bought 0 shares, with a net sale of 40,693 shares. During the past 18 months, 583,370 shares of KalVista Pharmaceuticals Inc (KALV) were sold and 1,251,017 shares were bought by its insiders, resulting in a net purchase of 667,647 shares.

KalVista Pharmaceuticals Inc (KALV)'s detailed insider trading history can be found in Insider Trading Tracker table.

KalVista Pharmaceuticals Inc Insider Transactions

No Available Data

Vivo Ventures Vi Affiilates Fund, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Vivo Ventures Vi Affiilates Fund, L.p.. You might contact Vivo Ventures Vi Affiilates Fund, L.p. via mailing address: 575 High Street, Suite 201, Palp Alto California Ca 94301.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.